Changes in platelet function in pregnancies complicated by fetal growth retardation.
Platelet function was investigated in three patients with severely decreased fetal growth rates detected by ultrasound scanning. Only one patient had hypertension, which was mild and developed after decreased fetal growth and altered platelet responses had been detected. Much higher concentrations of platelet-activating factor (PAF) (20-500 nM) were required to stimulate maximal platelet aggregation in all three patients compared with the concentrations of PAF (5-10 nM) required in control pregnancies of similar gestational age. In a fourth patient, platelet desensitisation was observed 5 weeks before the detection of decreased fetal growth. These results are similar to those observed in women with hypertensive disorders of pregnancy, and indicate that there may be a similar change in platelet function in gestational hypertension and in fetal growth retardation, although the clinical manifestations are different.
Ahmed
Y
Y
Institute of Obstetrics and Gynaecology, Royal Postgraduate Medical School, Hammersmith Hospital, London, U.K.
Sullivan
M H
MH
Pearce
J M
JM
Elder
M G
MG
D001792:Blood Platelets / Q000502:physiology*; D005260:Female; D005317:Fetal Growth Retardation / Q000097:blood* / Q000000981:diagnostic imaging; D006801:Humans; D010972:Platelet Activating Factor / Q000378:metabolism / Q000494:pharmacology; D010974:Platelet Aggregation; D011247:Pregnancy; D011248:Pregnancy Complications / Q000097:blood* / Q000000981:diagnostic imaging; D014463:Ultrasonography
D010972:Platelet Activating Factor